Who Supplies Trastuzumab? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Trastuzumab exports, with 179+ registered manufacturers shipping to buyers across 108+ countries — yet a handful of companies dominate the shipments. MYLAN LABORATORIES LIMITED holds the largest share at 51.7% (export value: $39.9M). Close behind, BIOCON BIOLOGICS INDIA LIMITED (11.8%, $9.1M). ZYDUS LIFESCIENCES LIMITED (4.5%, $3.4M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Trastuzumab? Top Manufacturers & Their Buyers
Flow of Trastuzumab from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Trastuzumab Supplier Network — Key Market Intelligence
The Trastuzumab export market from India is led by MYLAN LABORATORIES LIMITED, which alone commands a 51.7% share, shipping $39.9M worth of product across 503 shipments. The second-largest exporter, BIOCON BIOLOGICS INDIA LIMITED, contributes $9.1M (11.8%) to the overall market. Combined, the top two suppliers alone account for 63.5% of all Trastuzumab exports, indicating a relatively concentrated supply base.
Across all 179 tracked manufacturers, the total Trastuzumab export value stands at $77.2M from 1.9K shipments. The market average shipment value is $41.0K. The single largest buyer relationship in terms of trade value is MYLAN IRELAND LIMITED, receiving $12.6M worth of product.
The combined buyer network spans 22 named purchasing companies, including MYLAN IRELAND LIMITED, BIOSIMILAR COLLABORATIONS IRELAND L, ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC, MYLAN IRELAND LTD, PII OST-WEST EXPRESS and 17 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1MYLAN LABORATORIES LIMITED
MYLAN LABORATORIES LIMITED is the first-largest Trastuzumab exporter from India, with a market share of 51.7% and a total export value of $39.9M across 503 shipments. Their average shipment value of $79.4K is above the market average of $41.0K, suggesting premium or bulk contract pricing.
MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MYLAN IRELAND LIMITED — $12.6M across 159 shipments (31.6% of this supplier's total exports)
• BIOSIMILAR COLLABORATIONS IRELAND L — $8.8M across 111 shipments (22.0% of this supplier's total exports)
• ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC — $8.2M across 103 shipments (20.4% of this supplier's total exports)
• MYLAN IRELAND LTD — $6.3M across 80 shipments (15.9% of this supplier's total exports)
• PII OST-WEST EXPRESS — $4.0M across 51 shipments (10.1% of this supplier's total exports)
Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $79.4K is 93% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.
2BIOCON BIOLOGICS INDIA LIMITED
BIOCON BIOLOGICS INDIA LIMITED is the second-largest Trastuzumab exporter from India, with a market share of 11.8% and a total export value of $9.1M across 39 shipments. Their average shipment value of $233.8K is above the market average of $41.0K, suggesting premium or bulk contract pricing.
BIOCON BIOLOGICS INDIA LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• BIOCON BIOLOGICS UK LIMITED — $4.0M across 17 shipments (44.3% of this supplier's total exports)
• XXOSIXXLARXXNEWXX LIXXTED — $3.1M across 13 shipments (34.3% of this supplier's total exports)
• RV HEALTH CARE PTE LTD — $945.1K across 4 shipments (10.4% of this supplier's total exports)
• XXOCOXXBIOXXGICXXUK — $506.1K across 2 shipments (5.5% of this supplier's total exports)
• GETZ PHARMA PVT LTD — $500.7K across 2 shipments (5.5% of this supplier's total exports)
Key Insight: BIOCON BIOLOGICS INDIA LIMITED's per-shipment value of $233.8K is 470% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.
3ZYDUS LIFESCIENCES LIMITED
ZYDUS LIFESCIENCES LIMITED is the third-largest Trastuzumab exporter from India, with a market share of 4.5% and a total export value of $3.4M across 68 shipments. Their average shipment value of $50.6K is above the market average of $41.0K, suggesting premium or bulk contract pricing.
ZYDUS LIFESCIENCES LIMITED serves 5 named buyers in our database. ZYDUS PHARMACEUTICALS M?XICO S.A. D is the dominant customer, accounting for 79.1% of this supplier's tracked business. Top customers include:
• ZYDUS PHARMACEUTICALS M?XICO S.A. D — $2.7M across 54 shipments (79.1% of this supplier's total exports)
• KIMIA FARMA TBK, PT — $261.4K across 5 shipments (7.6% of this supplier's total exports)
• KIMIA FARMA TBK, PT — $185.4K across 4 shipments (5.4% of this supplier's total exports)
• MEGA LIFESCIENCES PT — $140.8K across 3 shipments (4.1% of this supplier's total exports)
• RIPPLE PHARMACEUTICA — $130.7K across 3 shipments (3.8% of this supplier's total exports)
Key Insight: ZYDUS LIFESCIENCES LIMITED's per-shipment value of $50.6K is 23% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.
4RELIANCE LIFE SCIENCES PRIVATE LIMITED
RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fourth-largest Trastuzumab exporter from India, with a market share of 4.2% and a total export value of $3.2M across 75 shipments. Their average shipment value of $43.2K is above the market average of $41.0K, suggesting premium or bulk contract pricing.
RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. GENERAL FOREIGN TRADE ORGANIZATION is the dominant customer, accounting for 75.9% of this supplier's tracked business. Top customers include:
• GENERAL FOREIGN TRADE ORGANIZATION — $2.5M across 57 shipments (75.9% of this supplier's total exports)
• SEAN DOMINICAN SRL — $336.1K across 8 shipments (10.4% of this supplier's total exports)
• LEVANT PULSE — $250.2K across 6 shipments (7.7% of this supplier's total exports)
• OCTELLE CO., LTD — $105.2K across 2 shipments (3.3% of this supplier's total exports)
• PHARMACHEM PRIVATE L — $87.7K across 2 shipments (2.7% of this supplier's total exports)
Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED's per-shipment value of $43.2K is 5% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.
5BIOCON BIOLOGICS LIMITED
BIOCON BIOLOGICS LIMITED is the fifth-largest Trastuzumab exporter from India, with a market share of 1.6% and a total export value of $1.2M across 6 shipments. Their average shipment value of $201.9K is above the market average of $41.0K, suggesting premium or bulk contract pricing.
BIOCON BIOLOGICS LIMITED serves 1 named buyer in our database. MEDMART PHARMA (PVT) LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• MEDMART PHARMA (PVT) LTD — $1.2M across 6 shipments (100.0% of this supplier's total exports)
Key Insight: BIOCON BIOLOGICS LIMITED's per-shipment value of $201.9K is 392% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.
6MEDWISE OVERSEAS PRIVATE LIMITED
MEDWISE OVERSEAS PRIVATE LIMITED is the fifth-largest Trastuzumab exporter from India, with a market share of 1.5% and a total export value of $1.1M across 4 shipments. Their average shipment value of $281.8K is above the market average of $41.0K, suggesting premium or bulk contract pricing.
MEDWISE OVERSEAS PRIVATE LIMITED serves 3 named buyers in our database. TO MEDICAMENTOS CONS is the dominant customer, accounting for 55.5% of this supplier's tracked business. Top customers include:
• TO MEDICAMENTOS CONS — $625.7K across 2 shipments (55.5% of this supplier's total exports)
• TO. — $409.1K across 1 shipments (36.3% of this supplier's total exports)
• TO. — $92.4K across 0 shipments (8.2% of this supplier's total exports)
Key Insight: MEDWISE OVERSEAS PRIVATE LIMITED's per-shipment value of $281.8K is 587% above the market average of $41.0K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Trastuzumab Flows
Once Trastuzumab leaves the manufacturing plants of companies like MYLAN LABORATORIES LIMITED and BIOCON BIOLOGICS INDIA LIMITED, it travels to 5 destination markets with a combined import value of $77.2M. Netherlands absorbs the largest share at 37.9% ($29.3M), followed by Turkey (13.1%) and Ukraine (5.6%).
In Netherlands — the top destination — named importers include MYLAN IRELAND LIMITED, BIOSIMILAR COLLABORATIONS IRELAND L, MYLAN IRELAND LTD. In Turkey, key buyers are ABDI IBRAHIM ILAC SANAYI VE TICARET, ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC.
This geographic spread reflects Trastuzumab's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Trastuzumab Go? Top Importing Countries & Their Buyers
Trade flow of Trastuzumab exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Netherlands
Netherlands ranks as the first-largest destination for Trastuzumab imports from India, with a total trade value of $29.3M across 219 shipments — representing a 37.9% share of all Trastuzumab exports. The average shipment value of $133.6K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Trastuzumab importers in Netherlands: MYLAN IRELAND LIMITED is the largest buyer, accounting for 43.1% ($12.6M) of this market's total imports.
• MYLAN IRELAND LIMITED — $12.6M (43.1% of Netherlands's total)
• BIOSIMILAR COLLABORATIONS IRELAND L — $8.8M (30.1% of Netherlands's total)
• MYLAN IRELAND LTD — $7.3M (24.9% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $133.6K (226% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Trastuzumab imports from India.
2Turkey
Turkey ranks as the second-largest destination for Trastuzumab imports from India, with a total trade value of $10.2M across 28 shipments — representing a 13.1% share of all Trastuzumab exports. The average shipment value of $362.6K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Trastuzumab importers in Turkey: ABDI IBRAHIM ILAC SANAYI VE TICARET is the largest buyer, accounting for 80.4% ($8.2M) of this market's total imports.
• ABDI IBRAHIM ILAC SANAYI VE TICARET — $8.2M (80.4% of Turkey's total)
• ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC — $1.9M (18.8% of Turkey's total)
Key Insight: Turkey's per-shipment average of $362.6K (784% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Turkey is a key market for Trastuzumab imports from India.
3Ukraine
Ukraine ranks as the third-largest destination for Trastuzumab imports from India, with a total trade value of $4.3M across 10 shipments — representing a 5.6% share of all Trastuzumab exports. The average shipment value of $429.6K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Trastuzumab importers in Ukraine: PII OST-WEST EXPRESS is the largest buyer, accounting for 100.0% ($4.3M) of this market's total imports.
• PII OST-WEST EXPRESS — $4.3M (100.0% of Ukraine's total)
Key Insight: Ukraine's per-shipment average of $429.6K (947% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Ukraine is a key market for Trastuzumab imports from India.
4Brazil
Brazil ranks as the fourth-largest destination for Trastuzumab imports from India, with a total trade value of $4.1M across 19 shipments — representing a 5.4% share of all Trastuzumab exports. The average shipment value of $217.7K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Trastuzumab importers in Brazil: BIOCON BIOLOGICS UK LIMITED is the largest buyer, accounting for 97.7% ($4.0M) of this market's total imports.
• BIOCON BIOLOGICS UK LIMITED — $4.0M (97.7% of Brazil's total)
• LIBBS FARMACEUTICA LTDA. — $1.7M (42.0% of Brazil's total)
Key Insight: Brazil's per-shipment average of $217.7K (430% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Trastuzumab imports from India.
5United States
United States ranks as the fifth-largest destination for Trastuzumab imports from India, with a total trade value of $3.0M across 7 shipments — representing a 3.9% share of all Trastuzumab exports. The average shipment value of $428.1K is above the global average of $41.0K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Trastuzumab importers in United States: XXOSIXXLARXXNEWXX LIXXTED is the largest buyer, accounting for 104.4% ($3.1M) of this market's total imports.
• XXOSIXXLARXXNEWXX LIXXTED — $3.1M (104.4% of United States's total)
Key Insight: United States's per-shipment average of $428.1K (943% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Trastuzumab imports from India.
People Also Ask — Trastuzumab Supplier & Trade Network
Who are the top suppliers of Trastuzumab from India?+
Which companies buy Trastuzumab from Indian manufacturers?+
Where does Trastuzumab exported from India go?+
What is the market share of the top Trastuzumab supplier from India?+
What is the average shipment value for Trastuzumab exports from India?+
Is Trastuzumab manufactured in India and exported globally?+
Which country imports the most Trastuzumab from India?+
Who are the buyers of Trastuzumab in Turkey?+
How concentrated is the Trastuzumab supplier market in India?+
How do I find verified buyers for Trastuzumab in specific countries?+
Trastuzumab Trade Network — Key Takeaways
- 1MYLAN LABORATORIES LIMITED is India's dominant Trastuzumab exporter with a 51.7% market share and $39.9M in total exports — making it the single most important sourcing entity in this market.
- 2The top 179 suppliers collectively account for 75.2% of all tracked Trastuzumab exports, with a combined trade value of $77.2M.
- 3Netherlands is the largest destination market, absorbing 37.9% of India's Trastuzumab exports ($29.3M). Turkey (13.1%) and Ukraine (5.6%) follow.
- 4With 1.9K total shipments averaging $41.0K each, the Trastuzumab export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include MYLAN IRELAND LIMITED, BIOSIMILAR COLLABORATIONS IRELAND L, BIOCON BIOLOGICS UK LIMITED, XXOSIXXLARXXNEWXX LIXXTED — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 108 countries
Network value: $77.2M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Trastuzumab — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Trastuzumab.
- 2.Flow Mapping: 179 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,882 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 108 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,882 Verified Shipments
179 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists